Rak Sargent

Rak Sargent has a strong background in the pharmaceutical industry, with experience in marketing and sales roles. Rak is currently working as a Senior Director at Deciphera Pharmaceuticals, leading the launch of Vimseltinib. Prior to this, Rak has held positions at Centrexion Therapeutics Corp, AMAG Pharmaceuticals, Flexion Therapeutics, Instrumentation Laboratory, Sanofi Genzyme, and Pfizer. At AMAG Pharmaceuticals, Rak successfully launched the label extension of Feraheme, achieving significant growth for the brand. During their time at Flexion Therapeutics, they played a key role in the pre-launch and launch marketing initiatives for Zilretta. At Instrumentation Laboratory, Rak was responsible for the development of an IVD software solution, implementing DFSS principles. Rak also has experience in sales, achieving exceptional results in competitive marketplaces for various medical products.

Rak Sargent completed a Bachelor of Science degree in Education with a specialization in Biology at the University of New Hampshire.